Arix Bioscience PLC Fundamentals Datasheet and Stock Analysis

Profile

Arix Bioscience plc is a United Kingdom-based healthcare and life science company. The Company is a holding company that is focused on generating value from the development and commercialization of technologies and discoveries. Its principal activity is to source, finance and develop healthcare and life science businesses across the world. The Company focuses on acquiring interests in, and provide operational oversight to, healthcare and life science businesses with which it partners in the healthcare and life science sector. The Company holds interests in BioMotiv, OptiKira LLC, Autolus, Depixus SAS, Verona Pharma plc and Artios Pharma Ltd. The Company has agreements with universities in the United Kingdom, Europe and Australia, providing direct access to new technologies. It also has access to a range of research projects from the United States academic institutions. Its subsidiaries include Arix Bioscience Holdings Limited, Arix US Inc and Arthurian Life Sciences GP Limited.

  • Current Price:
     209.00p
  • Industry:
     Financials
  • Sector:
     Financial Services
  • ISIN:
     GB00BD045071
  • Market Sector:
     MAIN
  • Main Indices:
     N/A
  • Country of register:
     Great Britain
  • Currency:
     N/A
  • Shares in Issue:
     135m
  • Market Cap:
     £0m
  • Date Listed:
     17/02/2017
Operation Breakdown
Geographical - by origin (turnover)
Product (turnover)

Loading...

Activity Data Not Available

Company Information

Chairman: Jonathan Peacock  Non-Executive Director: Meghan FitzGerald Giles Kerr  Deputy Chairman: Christopher Evans  Senior Independent Non-Executive Director: Franz Bernhard Humer  Chief Finance Officer: James Rawlingson  Chief Executive Officer : Joseph Anderson  Independent Non-Executive Director: David U?Prichard, John Matthew Patrick Hutton Trevor Jones  Chief Scientific Officer: Graeme Smith  

Analysis
Composite Ranking: 55
Historic EPS Ranking: 45
Forecast EPS Ranking: 35
Price Relative Strength: 44
Industry Strength: A
SMR Ranking: 
ROCE Ranking: F
Accumulation/Dist: 
Mkt Accumulation/Dist: C
Unbroken Annual EPS: E
Unbroken Interim EPS: E
PEG Current Ranking: A
PEG Forecast Ranking: A
PE Current Ranking: A
PE Forecast Ranking: H
Margin Current Ranking: H
Margin Forecast Ranking: A
Chart
Add Indicator




loading




Takes the average of data over a period of time, and migrates the period across the data series one data point at a time. This formula smooths a data series and makes analysing volatile data easier.
Fundamentals
201620172018E2019E
Day/Month31/1231/1231/1231/12
Revenue£m0.641.86£m1.652.00
Operating Profit/(loss)£m(8.30)(3.59)£m0.000.00
Profit Before Tax£m(9.53)(7.69)£m2.50(2.70)
Profit After Tax£m(8.84)(7.47)£m0.000.00
Profit After Tax (from discontinued operations)£m0.000.00£m0.000.00
Overall Profit for the Period£m(8.84)(7.47)£m0.000.00
EPS Growth%0.000.00%0.000.00
Earnings Per Sharep(0.36)(0.11)p0.03(0.02)
Op. Cash Flow P/Sp0.000.00£0.000.00
Cash Flow P/S Grth%0.000.00%0.000.00
Net Cash Flow P/Sp0.000.00£0.000.00
Capital Exp P/S£0.000.00£0.000.00
Tax Rate%0.000.00%0.000.00
P/E Ratiox0.000.00x6,966.700.00
P/E Growth£0.000.00£0.000.00
Turnover Per Share£0.000.00£0.000.00
Pre-Tax Profit / Share£0.000.00£0.000.00
Operating Margin%(1,296.88)(193.01)%0.000.00
ROCE%(21.66)(5.33)%0.000.00
ROE%0.000.00%0.000.00
Mkt Cap£m0.00262.79£m0.000.00
Dividend Per Sharep0.000.00p0.000.00
DPS Growth%0.000.00%0.000.00
Dividend Yield%0.000.00%0.000.00
Dividend Coverx0.000.00x0.000.00
Shareholder Funds£m46.33146.44£m0.000.00
Net Borrowings£m(28.93)(74.94)£m0.000.00
Net Assets£m46.33146.44£m0.000.00
Net Assets P/S£0.000.00£0.000.00
Financials
Latest Forecast
Div Yield0.0%0.0%
Div Cover0.0%0.0%
Op Margin-193.0%151.5%
ROCE0.0%
Director Deals
Traded Action Notifier Price Amount Value
20-Mar-18BuyJonathan Peacock225.00p 90,000£202,500
02-Jun-17BuyJoseph Anderson2.06p55,000£113,355.01
02-Jun-17BuyJoseph Anderson206.10p 55,000£113,355.01
02-Jun-17BuyJonathan Peacock2.06p28,016£57,740.98
02-Jun-17BuyJonathan Peacock206.10p 28,016£57,740.98
02-Jun-17BuyJames Rawlingson2.06p26,000£53,586
02-Jun-17BuyJames Rawlingson206.10p 26,000£53,586
08-May-17BuyJames Rawlingson2.02p11,484£23,242.47
08-May-17BuyJonathan Peacock202.39p 11,484£23,242.47
08-May-17BuyJames Rawlingson202.39p 11,484£23,242.47
  Rows per page
Shareholders
135m    Major: 72%    Director: 6%
Notifier Holding Value
Christopher Evans7,316,03915,290,521.51
Jonathan Peacock129,500270,655
Joseph Anderson55,000114,950
Giles Kerr31,66366,175.67
Meghan FitzGerald30,34463,418.96
  Rows per page
Gearing & Cover
News
News Title Date Time Source
Result of AGM17-May-1812:29RNS
Update on Iterum proposed NASDAQ IPO17-May-1807:00RNS
Autolus Files for Proposed US IPO08-May-1807:00RNS
Arix notes Iterum?s proposed US IPO02-May-1810:10RNS
Annual Results 201723-Apr-1807:00RNS
Notice of Annual Results16-Apr-1807:25RNS
Arix to present at HC Wainwright on 10 April05-Apr-1807:00RNS-R
Holding(s) in Company04-Apr-1809:01RNS
Total Voting Rights04-Apr-1809:00RNS
Holding(s) in Company26-Mar-1813:40RNS
First PagePrev PageNext Page  Rows per page
Broker Opinion
Date Broker Name Rec Price Old Price Target New Price Target Broker Change

No data

  Rows per page
Notes

This functionality requires you to login

Click here to login
Or register for a new account